ADDvise Group
2,315
SEK
+0,22 %
ADDV B
First North Stockholm
Medical Equipment & Services
Health Care
Mindre end 1K følgere
+0,22%
-35,61%
-32,61%
-43,12%
-61,67%
-82,75%
-66,15%
+235,51%
-24,31%
ADDvise Group offers complete solutions for healthcare and research units, which include laboratory equipment, protective ventilation, and various consumables. The business is managed based on two business segments: Lab and Healthcare. The customers are found mainly in the Nordic market, but also in the rest of the international market and include both customers in the private and public sectors. The company is headquartered in Stockholm.
Læs mereMarkedsværdi
460,3 mio. SEK
Aktieomsætning
1,08 mio. SEK
Omsætning
-
EBIT %
-
P/E
4,37
Udbytteafkast, %
-
Finanskalender
20.2
2025
Årsrapport '24
16.4
2025
Delårsrapport Q1'25
6.5
2025
Generalforsamling '25
ViserAlle indholdstyper

ADDvise Group, Audiocast with teleconference, Q4'24
ADDvise Group AB: ADDvise receives order worth EUR 2.6 million
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
ADDvise Group AB: ADDvise receives allocation decision worth approximately SEK 72 million
ADDvise Group AB: ADDvise explores potential divestment of its subsidiary Germa
ADDvise Group AB: ADDvise receives order worth USD 1.8 million
ADDvise Group AB: ADDvise streamlines organization through new business area structure
Redeye: ADDvise Q3 2024 - Comparables set to ease from Q4 2024e

ADDvise Group, Audiocast with teleconference, Q3'24
ADDvise Group AB: Interim report 2024, January 1-September 30
ADDvise Group AB: ADDvise Group's nomination committee for the Annual General Meeting 2025
ADDvise Group AB: Invitation to presentation of interim report July 1 - September 30, 2024
ADDvise Group AB: ADDvise receives order worth USD 1.3 million
ADDvise Group AB: ADDvise receives order worth SEK 32.5 million
Redeye: Serial acquirers Q2 2024 - Comparing ROIC on an apples-to-apples basis
ADDvise Group AB: Fredrik Celsing appointed new chairman of the board of directors as of 1 September - extraordinary general meeting on 29 August cancelled
ADDvise Group AB: Chairman of the board and incoming CEO of ADDvise divests shares of series A and acquires shares of series B
ADDvise Group AB: Departing CEO of ADDvise divests shares of series A to a major shareholder of ADDvise
Redeye: ADDvise Q2 2024 - Road to recovery
